IL164341A0 - Substituted amino isoxazoline derivatives and their use as anti-depressants - Google Patents
Substituted amino isoxazoline derivatives and their use as anti-depressantsInfo
- Publication number
- IL164341A0 IL164341A0 IL16434103A IL16434103A IL164341A0 IL 164341 A0 IL164341 A0 IL 164341A0 IL 16434103 A IL16434103 A IL 16434103A IL 16434103 A IL16434103 A IL 16434103A IL 164341 A0 IL164341 A0 IL 164341A0
- Authority
- IL
- Israel
- Prior art keywords
- depressants
- substituted amino
- isoxazoline derivatives
- amino isoxazoline
- derivatives
- Prior art date
Links
- XPZOKPQZEPSMFC-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazol-3-amine Chemical class NC1=NOCC1 XPZOKPQZEPSMFC-UHFFFAOYSA-N 0.000 title 1
- 230000001430 anti-depressive effect Effects 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 title 1
- 229940005513 antidepressants Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076239 | 2002-04-02 | ||
| PCT/EP2003/003245 WO2003082878A1 (en) | 2002-04-02 | 2003-03-27 | Substituted amino isoxazoline derivatives and their use as anti-depressants. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL164341A0 true IL164341A0 (en) | 2005-12-18 |
Family
ID=28459528
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16434103A IL164341A0 (en) | 2002-04-02 | 2003-03-27 | Substituted amino isoxazoline derivatives and their use as anti-depressants |
| IL164341A IL164341A (en) | 2002-04-02 | 2004-09-28 | Transformed history of amino isoxazoline and their use as antidepressants |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL164341A IL164341A (en) | 2002-04-02 | 2004-09-28 | Transformed history of amino isoxazoline and their use as antidepressants |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7265103B2 (da) |
| EP (1) | EP1492796B1 (da) |
| JP (1) | JP4580653B2 (da) |
| KR (1) | KR20040093061A (da) |
| CN (1) | CN100349897C (da) |
| AR (1) | AR039207A1 (da) |
| AT (1) | ATE372342T1 (da) |
| BR (1) | BR0308309A (da) |
| CA (1) | CA2480113C (da) |
| DE (1) | DE60316134T2 (da) |
| DK (1) | DK1492796T3 (da) |
| EA (1) | EA008189B1 (da) |
| ES (1) | ES2292949T3 (da) |
| HK (1) | HK1080072A1 (da) |
| HR (1) | HRP20040871A2 (da) |
| IL (2) | IL164341A0 (da) |
| MX (1) | MXPA04008626A (da) |
| NO (1) | NO20044645L (da) |
| NZ (1) | NZ536109A (da) |
| PL (1) | PL211708B1 (da) |
| PT (1) | PT1492796E (da) |
| TW (1) | TWI286138B (da) |
| WO (1) | WO2003082878A1 (da) |
| ZA (1) | ZA200407904B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
| ATE387455T1 (de) * | 2002-08-21 | 2008-03-15 | Janssen Pharmaceutica Nv | C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva |
| JP2008521771A (ja) | 2004-11-26 | 2008-06-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体 |
| CA2691704A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| EP2406243B1 (en) | 2009-03-10 | 2014-05-07 | Takeda Pharmaceutical Company Limited | Benzofuran derivatives |
| US20130062732A1 (en) | 2011-09-08 | 2013-03-14 | International Business Machines Corporation | Interconnect structures with functional components and methods for fabrication |
| CN105801510A (zh) * | 2016-04-08 | 2016-07-27 | 李勇 | 一种治疗抑郁症的药物组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2055011T3 (es) | 1988-09-19 | 1994-08-16 | Akzo Nv | Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano. |
| AU710059B2 (en) * | 1996-01-05 | 1999-09-09 | Aventis Pharmaceuticals Inc. | 4,5-dihydronaphth(1,2-C)isoxazoles and derivatives thereof having CNS activity |
| US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
| MXPA03007432A (es) * | 2001-02-21 | 2003-11-18 | Janssen Pharmaceutica Nv | Derivados de isoxazolinas y su uso como antidepresivos. |
| AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
| ATE387455T1 (de) * | 2002-08-21 | 2008-03-15 | Janssen Pharmaceutica Nv | C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva |
-
2003
- 2003-03-27 NZ NZ536109A patent/NZ536109A/en unknown
- 2003-03-27 AT AT03714897T patent/ATE372342T1/de not_active IP Right Cessation
- 2003-03-27 EP EP03714897A patent/EP1492796B1/en not_active Expired - Lifetime
- 2003-03-27 MX MXPA04008626A patent/MXPA04008626A/es active IP Right Grant
- 2003-03-27 IL IL16434103A patent/IL164341A0/xx unknown
- 2003-03-27 HR HR20040871A patent/HRP20040871A2/hr not_active Application Discontinuation
- 2003-03-27 CN CNB038074192A patent/CN100349897C/zh not_active Expired - Fee Related
- 2003-03-27 EA EA200401297A patent/EA008189B1/ru not_active IP Right Cessation
- 2003-03-27 US US10/510,220 patent/US7265103B2/en not_active Expired - Lifetime
- 2003-03-27 WO PCT/EP2003/003245 patent/WO2003082878A1/en not_active Ceased
- 2003-03-27 PT PT03714897T patent/PT1492796E/pt unknown
- 2003-03-27 DK DK03714897T patent/DK1492796T3/da active
- 2003-03-27 BR BR0308309-8A patent/BR0308309A/pt not_active IP Right Cessation
- 2003-03-27 KR KR10-2004-7012757A patent/KR20040093061A/ko not_active Ceased
- 2003-03-27 JP JP2003580343A patent/JP4580653B2/ja not_active Expired - Fee Related
- 2003-03-27 ES ES03714897T patent/ES2292949T3/es not_active Expired - Lifetime
- 2003-03-27 CA CA2480113A patent/CA2480113C/en not_active Expired - Fee Related
- 2003-03-27 PL PL371630A patent/PL211708B1/pl unknown
- 2003-03-27 HK HK05112213.1A patent/HK1080072A1/zh unknown
- 2003-03-27 DE DE60316134T patent/DE60316134T2/de not_active Expired - Lifetime
- 2003-04-01 AR ARP030101126A patent/AR039207A1/es unknown
- 2003-04-01 TW TW092107328A patent/TWI286138B/zh not_active IP Right Cessation
-
2004
- 2004-09-28 IL IL164341A patent/IL164341A/en not_active IP Right Cessation
- 2004-09-30 ZA ZA200407904A patent/ZA200407904B/xx unknown
- 2004-10-27 NO NO20044645A patent/NO20044645L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL173726A0 (en) | N,n-dihalogenated amino acids and derivatives | |
| PT2702871T (pt) | Biotecido de colagénio e sua utilização | |
| AU2003254844A1 (en) | Substituted amino compounds and use thereof | |
| PL370766A1 (en) | Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors | |
| EP1596808A4 (en) | L-DOPA AMID DERIVATIVES AND THEIR USE | |
| IL168747A0 (en) | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents | |
| IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
| EG25683A (en) | Benzoxazine derivatives and uses thereof | |
| PL375195A1 (en) | Aminoalcohol derivatives | |
| PL377770A1 (pl) | Podstawione benzoksazynony i ich zastosowanie | |
| IL174479A0 (en) | Hemiasterlin derivatives and uses thereof | |
| SI1551805T1 (sl) | Substituirani gama-fenil-delta-laktami in njihova uporaba | |
| IL175817A0 (en) | Benzoxazine derivatives and uses thereof | |
| IL166821A0 (en) | Novel 1,4-diazabicycloalkane derivatives their preparation and use | |
| IL157470A0 (en) | Isoxazoline derivatives as anti-depressants | |
| AU2003268075A8 (en) | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents | |
| IL164341A0 (en) | Substituted amino isoxazoline derivatives and their use as anti-depressants | |
| AU2003231827A8 (en) | Pseudo-tissues and uses thereof | |
| GB2409796B (en) | Composition comprising proteinaceous material, its preparation and use | |
| GB0316910D0 (en) | Fluorocombretastatin and derivatives thereof | |
| PL1786759T3 (pl) | Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie | |
| GB0317376D0 (en) | Immunogenic protein and uses thereof | |
| GB0307231D0 (en) | 7-Nitroindoline derivatives and their uses | |
| EP1699809A4 (en) | PEPTIDE FROM AMNIOTIC LIQUID AND USES THEREOF | |
| EP1499338A4 (en) | 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSENES-17-ONE AND 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSTAN-17-ONE AND THEIR DERIVATIVES |